Chromosomal regions 17p and 9p are often affected in BC, disrupting the activity of tumour suppressor genes TP53 and CDKN2A. This LOH seems to be associated with reduced disease-free survival and high risk of disease progression [107,108]. This evidence concerns the gene TP53 and breast cancer.